Delivery Order SPE2DB20D3103-SPE2DB25FP9B5
- Not listed
- The Defense Logistics Agency awarded a $2,295.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Refresh Tears 0.5% eye drops (15ml units). This is a non-set-aside competitive award with an ultimate completion date of August 5, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL) with a ceiling value of $1,277.84 under a firm fixed-price contract structure. This is a non-set-aside award issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's...
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.39 firm-fixed-price delivery order is for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- This federal contract award is for the delivery of Refresh Tears 0.5% eye drops in 15ml bottles to the Defense Logistics Agency (DLA). The $1,578.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.36, is a Delivery Order for the supply of REFRESH TEARS 0.5% EYE DROP 15ML. The contract has a firm fixed price pricing type and an ultimate completion date of December 19, 2024. There was no set-aside designation used for this award. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops. The $1,254.10 firm fixed-price contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Refresh Tears 0.5% eye drops in 15 ml bottles, with a firm fixed price of $3,348.60 and a performance period ending on May 12, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562272559 REFRESH TEARS 0.5% eye drops. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 15ml bottles of the eye drops from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by September 25, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or...
- This contract award, SPE2DX15D3306|SPE2DX25FADAG, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Refresh Tears 0.5% eye drops in 15ml bottles. The $19,315.47 firm fixed-price delivery order has an ultimate completion date of October 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9B5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,381.67 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15 mL) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction executed under the company's broader pharmaceutical supply relationship with DLA. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen serves as a prime pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs and other government healthcare systems. The company's demonstrated capability to fulfill diverse federal medical supply requirements through open competition has positioned it as a critical vendor within the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/15/25 |